Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000069 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 1, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
15,000
Total Value
$511,078.58
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 5,000 | $7.80 | $39,000.00 | 241,384 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 1, 2026 | Sale | 2,237 | $93.85 | $209,932.83 | 239,147 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 1, 2026 | Sale | 2,263 | $94.75 | $214,409.75 | 236,884 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jul 1, 2026 | Sale | 500 | $95.47 | $47,736.00 | 236,384 | Direct | โ | View Details | |
Chief Operating Officer | Employee Warrant (right to buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 79,996 | Direct | โ | View Details |